Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-30 @ 8:32 PM
Study NCT ID:
NCT07493135
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-25
First Post:
2026-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor:
Suzhou Immunofoco Biotechnology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-19
First Submit QC Date:
None
Study First Post Date:
2026-03-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-19
Last Update Post Date:
2026-03-25
Last Update Post Date Type:
ACTUAL